Marshall Wace, LLP Sensus Healthcare, Inc. Transaction History
Marshall Wace, LLP
- $72.2 Billion
- Q2 2024
A detailed history of Marshall Wace, LLP transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 77,387 shares of SRTS stock, worth $455,035. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77,387
Previous 30,655
152.44%
Holding current value
$455,035
Previous $116,000
255.17%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding SRTS
# of Institutions
50Shares Held
3.28MCall Options Held
600Put Options Held
0-
Vanguard Group Inc Valley Forge, PA779KShares$4.58 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny392KShares$2.3 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY200KShares$1.17 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX167KShares$979,5490.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny166KShares$976,6680.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $97.3M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...